Bristol-Myers Squibb 10 Our non-U.
S.  businesses have significantly more direct customers.
Information on available direct customer product level inventory and corresponding out-movement information and the reliability of third-party demand information varies widely.
We limit our direct customer sales channel inventory reporting to where we can influence demand.
When this information does not exist or is otherwise not available, we have developed a variety of methodologies to estimate such data, including using historical sales made to direct customers and thirdparty market research data related to prescription trends and end-user demand.
Given the difficulties inherent in estimating third-party demand information, we evaluate our methodologies to estimate direct customer product level inventory and to calculate months on hand on an ongoing basis and make changes as necessary.
Factors that may affect our estimates include generic competition, seasonality of products, price increases, new product launches, new warehouse openings by direct customers, new customer stockings by direct customers and expected direct customer purchases for governmental bidding situations.
As such, all of the information required to estimate months on hand in the direct customer distribution channel for non-U.
S.  business for the year ended December 31, 2016 is not available prior to the filing of this annual report on Form 10-K.  We will disclose any product with levels of inventory in excess of one month on hand or expected demand, subject to a de minimis exception, in the next quarterly report on Form 10-Q.
Expenses
## Table 0 ##
** Change in excess of 100% Cost of products sold Cost of products sold include material, internal labor and overhead costs from our owned manufacturing sites, third-party processing costs and other supply chain costs managed by our global manufacturing and supply organization.
Cost of products sold also includes royalties and profit sharing attributed to licensed products and alliances, foreign currency hedge settlement gains and losses and the amortization of acquired developed technology costs from business combinations and regulatory approval milestones.
Cost of products sold typically vary between periods as a result of product mix and volume (particularly resulting from royalties and profit sharing expenses in connection with our alliances), changes in foreign currency, price, inflation and costs attributed to the rationalization of manufacturing sites resulting in accelerated depreciation, impairment charges and other stranded costs.  ?
Cost of products sold increased in 2016 primarily due to higher Eliquis profit sharing of $700 million, lower foreign currency hedge settlement gains and higher Puerto Rico excise tax.  ?
Cost of products sold remained relatively flat in 2015 as higher Eliquis profit sharing of $532 million was offset by favorable foreign exchange.
Marketing, selling and administrative Marketing, selling and administrative expenses include salary and benefit costs, third-party professional and marketing fees, outsourcing fees, shipping and handling costs, advertising and product promotion and other expenses that are not attributed to product manufacturing costs or research and development expenses.
Expenses are managed through regional commercialization organizations or global enabling functions such as finance, legal, information technology and human resources.
Certain expenses are shared with alliance partners based upon contractual agreements.
Expenses typically vary between periods due to new product launch promotional activities.  ?
Marketing, selling and administrative expenses increased in 2016 due to higher advertising and promotion and additional salesrelated activities supporting Opdivo partially offset by lower spend for virology products and favorable foreign exchange.  ?
Marketing, selling and administrative expenses remained relatively flat in 2015 as increased sales-related activities supporting Eliquis, Opdivo and the Hepatitis C Franchise were offset by favorable foreign exchange and $96 million of additional expenses related to the Branded Prescription Drug Fee in 2014 resulting from changes in IRS guidelines
See Note 10 Goodwill and Other Intangible Assets for further discussion of the accounting for goodwill and other intangible assets.
The estimated amount of RBC Bank (USA) revenue and net income (excluding integration costs) included in PNC’s consolidated income statement for 2012 was $1.0 billion and $273 million, respectively.
Upon closing and conversion of the RBC Bank (USA) transaction, subsequent to March 2, 2012, separate records for RBC Bank (USA) as a stand-alone business have not been maintained as the operations of RBC Bank (USA) have been fully integrated into PNC.
RBC Bank (USA) revenue and earnings disclosed above reflect management’s best estimate, based on information available at the reporting date.
The following table presents certain unaudited pro forma information for illustrative purposes only, for 2012 and 2011 as if RBC Bank (USA) had been acquired on January 1, 2011.
The unaudited estimated pro forma information combines the historical results of RBC Bank (USA) with the Company’s consolidated historical results and includes certain adjustments reflecting the estimated impact of certain fair value adjustments for the respective periods.
The pro forma information is not indicative of what would have occurred had the acquisition taken place on January 1, 2011.
In particular, no adjustments have been made to eliminate the impact of other-than-temporary impairment losses and losses recognized on the sale of securities that may not have been necessary had the investment securities been recorded at fair value as of January 1, 2011.
The unaudited pro forma information does not consider any changes to the provision for credit losses resulting from recording loan assets at fair value.
Additionally, the pro forma financial information does not include the impact of possible business model changes and does not reflect pro forma adjustments to conform accounting policies between RBC Bank (USA) and PNC.
Additionally, PNC expects to achieve further operating cost savings and other business synergies, including revenue growth, as a result of the acquisition that are not reflected in the pro forma amounts that follow.
As a result, actual results will differ from the unaudited pro forma information presented.
Table 57: RBC Bank (USA) and PNC Unaudited Pro Forma Results
## Table 1 ##
In connection with the RBC Bank (USA) acquisition and other prior acquisitions, PNC recognized $267 million of integration charges in 2012.
PNC recognized $42 million of integration charges in 2011 in connection with prior acquisitions.
The integration charges are included in the table above.
SALE OF SMARTSTREET Effective October 26, 2012, PNC divested certain deposits and assets of the Smartstreet business unit, which was acquired by PNC as part of the RBC Bank (USA) acquisition, to Union Bank, N. A.  Smartstreet is a nationwide business focused on homeowner or community association managers and had approximately $1 billion of assets and deposits as of September 30, 2012.
The gain on sale was immaterial and resulted in a reduction of goodwill and core deposit intangibles of $46 million and $13 million, respectively.
Results from operations of Smartstreet from March 2, 2012 through October 26, 2012 are included in our Consolidated Income Statement.
FLAGSTAR BRANCH ACQUISITION Effective December 9, 2011, PNC acquired 27 branches in the northern metropolitan Atlanta, Georgia area from Flagstar Bank, FSB, a subsidiary of Flagstar Bancorp, Inc.
The fair value of the assets acquired totaled approximately $211.8 million, including $169.3 million in cash, $24.3 million in fixed assets and $18.2 million of goodwill and intangible assets.
We also assumed approximately $210.5 million of deposits associated with these branches.
No deposit premium was paid and no loans were acquired in the transaction.
Our Consolidated Income Statement includes the impact of the branch activity subsequent to our December 9, 2011 acquisition.
BANKATLANTIC BRANCH ACQUISITION Effective June 6, 2011, we acquired 19 branches in the greater Tampa, Florida area from BankAtlantic, a subsidiary of BankAtlantic Bancorp, Inc.
The fair value of the assets acquired totaled $324.9 million, including $256.9 million in cash, $26.0 million in fixed assets and $42.0 million of goodwill and intangible assets.
We also assumed approximately $324.5 million of deposits associated with these branches.
A $39.0 million deposit premium was paid and no loans were acquired in the transaction.
Our Consolidated Income Statement includes the impact of the branch activity subsequent to our June 6, 2011 acquisition.
SALE OF PNC GLOBAL INVESTMENT SERVICING On July 1, 2010, we sold PNC Global Investment Servicing Inc.  (GIS), a leading provider of processing, technology and business intelligence services to asset managers, brokerdealers and financial advisors worldwide, for $2.3 billion in cash pursuant to a definitive agreement entered into on February 2, 2010.
This transaction resulted in a pretax gain of $639 million, net of transaction costs, in the third quarter of 2010.
This gain and results of operations of GIS through June 30, 2010 are presented as Income from discontinued operations, net of income taxes, on our Consolidated Income Statement.
As part of the sale agreement, PNC has agreed to provide certain transitional services on behalf of GIS until completion of related systems conversion activities.
The following table presents the assignment of the allowance for loan and lease losses and the categories of loans as a percentage of total loans.
Changes in the allocation over time reflect the changes in loan portfolio composition, risk profile and refinements to reserve methodologies.
For purposes of this presentation, a portion of the allowance for loan and lease losses has been assigned to loan categories based on the relative specific and pool allocation amounts to provide coverage for probable losses not covered in specific, pool and consumer reserve methodologies related to qualitative and measurement factors.
At December 31, 2012, the portion of the reserves for these factors was $42 million.
ALLOCATION OF ALLOWANCE FOR LOAN AND LEASE LOSSES
## Table 2 ##
(a) Includes home equity, credit card and other consumer.
SELECTED LOAN MATURITIES AND INTEREST SENSITIVITY
## Table 3 ##
At December 31, 2012, we had no pay-fixed interest rate swaps designated to commercial loans as part of fair value hedge strategies.
At December 31, 2012, $13.4 billion notional amount of receive-fixed interest rate swaps were designated as part of cash flow hedging strategies that converted the floating rate (1 month and 3 month LIBOR) on the underlying commercial loans to a fixed rate as part of risk management strategies.
TIME DEPOSITS OF $100,000 OR MORE Time deposits in foreign offices totaled $2.0 billion at December 31, 2012, substantially all of which were in denominations of $100,000 or more.
The following table sets forth maturities of domestic time deposits of $100,000 or more:
## Table 4 ##
COMMON STOCK PRICES/DIVIDENDS DECLARED The table below sets forth by quarter the range of high and low sale and quarter-end closing prices for The PNC Financial Services Group, Inc.  common stock and the cash dividends declared per common share.

<table><tr><td></td><td></td><td></td><td></td><td colspan="2">% Change</td></tr><tr><td>Dollar in Millions</td><td>2016</td><td>2015</td><td>2014</td><td>2016 vs. 2015</td><td>2015 vs. 2014</td></tr><tr><td>Cost of products sold</td><td>$4,946</td><td>$3,909</td><td>$3,932</td><td>27%</td><td>-1%</td></tr><tr><td>Marketing, selling and administrative</td><td>4,911</td><td>4,841</td><td>4,822</td><td>1%</td><td>—</td></tr><tr><td>Research and development</td><td>4,940</td><td>5,920</td><td>4,534</td><td>-17%</td><td>31%</td></tr><tr><td>Other (income)/expense</td><td>-1,285</td><td>-187</td><td>210</td><td>**</td><td>**</td></tr><tr><td>Total Expenses</td><td>$13,512</td><td>$14,483</td><td>$13,498</td><td>-7%</td><td>7%</td></tr></table>
<table><tr><td></td><td>For the Year Ended December 31</td></tr><tr><td>In millions</td><td>2012</td><td>2011</td></tr><tr><td>Total revenues</td><td>$15,721</td><td>$15,421</td></tr><tr><td>Net income</td><td>2,989</td><td>2,911</td></tr></table>
<table><tr><td></td><td colspan="2">2012</td><td colspan="2">2011</td><td colspan="2">2010</td><td colspan="2">2009</td><td colspan="2">2008</td></tr><tr><td>December 31Dollars in millions</td><td>Allowance</td><td>Loans to Total Loans</td><td>Allowance</td><td>Loans to Total Loans</td><td>Allowance</td><td>Loans to Total Loans</td><td>Allowance</td><td>Loans to Total Loans</td><td>Allowance</td><td>Loans toTotal Loans</td></tr><tr><td>Commercial</td><td>$1,131</td><td>44.7%</td><td>$1,180</td><td>41.3%</td><td>$1,387</td><td>36.7%</td><td>$1,869</td><td>34.8%</td><td>$1,668</td><td>39.4%</td></tr><tr><td>Commercial real estate</td><td>589</td><td>10.0</td><td>753</td><td>10.2</td><td>1,086</td><td>11.9</td><td>1,305</td><td>14.7</td><td>833</td><td>14.7</td></tr><tr><td>Equipment lease financing</td><td>54</td><td>3.9</td><td>62</td><td>4.0</td><td>94</td><td>4.2</td><td>171</td><td>3.9</td><td>179</td><td>3.7</td></tr><tr><td>Consumer (a)</td><td>1,415</td><td>33.2</td><td>1,458</td><td>35.4</td><td>1,227</td><td>36.6</td><td>957</td><td>34.0</td><td>929</td><td>29.9</td></tr><tr><td>Residential real estate</td><td>847</td><td>8.2</td><td>894</td><td>9.1</td><td>1,093</td><td>10.6</td><td>770</td><td>12.6</td><td>308</td><td>12.3</td></tr><tr><td>Total</td><td>$4,036</td><td>100.0%</td><td>$4,347</td><td>100.0%</td><td>$4,887</td><td>100.0%</td><td>$5,072</td><td>100.0%</td><td>$3,917</td><td>100.0%</td></tr></table>
<table><tr><td>December 31, 2012In millions</td><td>1 Yearor Less</td><td>1 Through5Years</td><td>After5 Years</td><td>GrossLoans</td></tr><tr><td>Commercial</td><td>$22,804</td><td>$48,428</td><td>$11,808</td><td>$83,040</td></tr><tr><td>Commercial real estate – Real estate projects</td><td>6,575</td><td>8,070</td><td>4,010</td><td>18,655</td></tr><tr><td>Total</td><td>$29,379</td><td>$56,498</td><td>$15,818</td><td>$101,695</td></tr><tr><td>Loans with:</td><td></td><td></td><td></td><td></td></tr><tr><td>Predetermined rate</td><td>$5,458</td><td>$11,320</td><td>$7,855</td><td>$24,633</td></tr><tr><td>Floating or adjustable rate</td><td>23,921</td><td>45,178</td><td>7,963</td><td>77,062</td></tr><tr><td>Total</td><td>$29,379</td><td>$56,498</td><td>$15,818</td><td>$101,695</td></tr></table>
<table><tr><td>December 31, 2012 – in millions</td><td>DomesticCertificatesofDeposit</td></tr><tr><td>Three months or less</td><td>$1,719</td></tr><tr><td>Over three through six months</td><td>1,190</td></tr><tr><td>Over six through twelve months</td><td>1,731</td></tr><tr><td>Over twelve months</td><td>2,691</td></tr><tr><td>Total</td><td>$7,331</td></tr></table>

Question: What was the total amount of the Equipment lease financing for Allowance in the years where Commercial greater than 1600 for Allowance? (in million)